Introduction
============

Septic shock, the most severe stage of the septic process, is a deadly disease defined as severe sepsis with hypotension that persists after resuscitation with intravenous fluid \[[@B1],[@B2]\]. Critically ill patients may display a state of functional immune system suppression, which predisposes them to infections with opportunistic bacteria found in the ICU environment \[[@B3]\] and results in excess morbidity and mortality.

To identify genes and/or cellular pathways involved in the pathogenesis of ICU-acquired sepsis, we initially undertook leukocyte genomic expression analysis of polytrauma patients who developed severe sepsis during their ICU stay as compared with trauma patients who suffered from sepsis not escalating to a higher septic stage \[[@B2],[@B4]\]. Following robust statistical selection of differentially expressed genes, results were compared with publicly available microarray datasets, thus creating a unique list of likely disease modifiers. Among these genes, aquaporin-1 (Aqp1), a water channel protein \[[@B5],[@B6]\], was one of the three genes found deregulated in all datasets.

Aqp1, a 28 kDa integral membrane protein \[[@B7]\], exists as a tetramer with intracellular N-termini and C-termini -- an organization similar to several ion channel proteins \[[@B8]\]. The functional significance of Aqp1 in migratory cells lies presumably in cell volume regulation and cytokinesis \[[@B9],[@B10]\]. Aquaporin-9, an isoform of Aqp1, is constitutively expressed and regulates water influx at the leading edge of migrating neutrophils \[[@B11]\]. However, the role of Aqp1 in the molecular events taking place after leukocyte activation by pathogens remains unclear.

Based on the findings of the genomic expression analysis of our initial polytrauma patient group, we hypothesized that Aqp1 expression is induced in leukocytes of critically ill patients afflicted with nosocomial sepsis in a manner dependent on sepsis severity. To address this hypothesis and to study potential underlying mechanisms, we measured levels of leukocyte Aqp1 expression in critically ill patients at ICU admission, upon diagnosis of sepsis and at occurrence of septic shock; in additional *in vitro* experiments we probed the capacity of lipopolysaccharide (LPS) to regulate Aqp1 expression in polymorphonuclear granulocytes (PMNs) and investigated potential signaling pathways and functions.

Materials and methods
=====================

The study was approved by the Evangelismos Hospital Research Ethics Committee and all procedures carried out on patients were in compliance with the Helsinki Declaration. Informed written consent was obtained from all patients' next-of--kin prior to any study procedure.

Gene expression profiling study population
------------------------------------------

We initially screened consecutive admissions of polytrauma patients to the Evangelismos Hospital ICU, Athens, Greece. Exclusion criteria were: no consent to participate, sepsis upon ICU admission, body mass index \>35 kg/m^2^, age \<18 years, pregnancy, brain death, end-stage cancer, total ICU stay \<3 days, re-admission or transfer from another ICU, contagious diseases (human immunodeficiency virus, hepatitis), and oral intake of corticosteroids at an equivalent dosage ≥1 mg/kg prednisone/day for a period \>1 month. The first five initially nonseptic patients (one female), who subsequently became septic were included in the study. Two blood samples were obtained per patient: the first upon admission to the ICU, and the second within 48 hours of sepsis. Total RNA was isolated and cRNAs were hybridized to Affymetrix Hu133A 2.0 GeneChips Affymetrix, Santa Clara, CA, USA according to the manufacturer's instructions. This dataset has been deposited in ArrayExpress \[ArrayExpress:E-MEXP-3621\]. All methods employed in the aforementioned gene expression profiling study are described in detail in Additional file [1](#S1){ref-type="supplementary-material"}.

Aqp1 gene expression in septic ICU patients: study population
-------------------------------------------------------------

Following the initial microarray study stated above, we sought to investigate Aqp1 leukocyte expression in critically ill adult, initially nonseptic, patients who were admitted to the multi-disciplinary ICU of Evangelismos Hospital and who subsequently developed sepsis and deteriorated to septic shock; an additional group of patients who did not develop sepsis during their stay in the ICU served as the control.

Prior to enrollment, we screened all consecutive admissions over a 12-month period for eligibility. Exclusion criteria were the same as those used for our initial gene expression profiling study population (above). Of the 118 subjects screened over the study period, finally 29 medical, surgical and trauma patients were enrolled in the study, 16 of whom developed septic shock and 13 who served as our control patients (did not develop sepsis during their stay in the ICU). Clinical data and blood samples were obtained from all patients enrolled. Patients were considered to have sepsis when they developed systemic inflammatory response syndrome as a result of documented infection, septic patients with evidence of organ dysfunction were considered to have severe sepsis, and septic patients with persisting hypotension (despite adequate fluid resuscitation) were considered to have septic shock, in accordance with international guidelines and recommendations \[[@B2],[@B4]\].

Following study enrollment, baseline (upon ICU admission) anthropometric data and detailed organ system-oriented medical history were recorded. A venous blood sample was drawn at three different time points: at the time of ICU admission (baseline), at the onset of sepsis (within 6 to 12 hours) and upon septic shock. In patients who did not develop sepsis, blood samples were drawn at admission and at ICU discharge only. The age of the septic patients ranged from 21 to 82 years whereas the age of the patients that did not develop sepsis varied from 31 to 82 years. The characteristics of the abovementioned patients are presented in Table [1](#T1){ref-type="table"}.

###### 

Characteristics of the two ICU patient groups

  **Characteristic**     **Sepsis/septic shock**   **Nonsepsis**   ***P*value**
  --------------------- ------------------------- --------------- --------------
  Number of patients               16                   13               
  Age (years)                    47 ± 18              57 ± 17          0.12
  Gender                                                                 
   Male                        13 (81.3%)            6 (46.2%)         0.06
   Female                       3 (18.7%)            7 (53.8%)    
  Diagnosis                                                              
   Medical                      5 (31.3%)            5 (38.5%)         0.71
   Surgical or trauma          11 (68.7%)            8 (61.5%)    
  ICU mortality                 6 (37.5%)             0 (0%)           0.02
  APACHE II score              15.3 ± 6.0           14.6 ± 5.0         0.76
  SOFA score                    8.3 ± 2.3            5.2 ± 1.8       \<0.001
  Sepsis day                    4.2 ± 1.8               N/A              
  Septic shock day             12.7 ± 10.0              N/A              

Data expressed as number (percentages) of total related variable and mean ± standard deviation. Student's *t* test or the chi-square test was used, as appropriate. APACHE II and SOFA scores were estimated at ICU admission; sepsis and septic shock days denote the days post-ICU admission when sepsis and septic shock developed, respectively. APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment.

Chemicals and reagents
----------------------

Whole blood was collected in Tempus Blood RNA tubes (Applied Biosystems, Life Technologies Corporation, Carlsbad, CA, USA). RNA extraction was performed with the Tempus spin RNA isolation kit (Applied Biosystems, Life Technologies Corporation). Taq DNA polymerase was purchased from Fermentas (Thermo Fisher Scientific Inc., Waltham, MA, USA), reverse transcriptase from New England Biolabs (Ipswich, MA, USA), the SYBR-Green assay from Finnzymes (Thermo Fisher Scientific, Waltham, MA, USA), and the nuclear extraction kit and the NF-κB (p65) transcription factor assay kit from Cayman Chemical Company (Ann Arbor, MI, USA). LPS, EF-24, dithiothreitol (DTT) and phenylmethylsulfonyl fluoride were from Sigma (Sigma-Aldrich Corp, St Louis, MO, USA). The PCR products were analyzed by agarose gel electrophoresis. All reagents used were of analytical grade.

Blood collection
----------------

Three milliliters of venous blood were collected within the first 24 hours post ICU admission, at the onset of sepsis (within 6 to 12 hours) and upon septic shock or discharge from the ICU. Samples were collected in tubes containing RNA stabilizing solution (Applied Biosystems, Life Technologies Corporation).

Total RNA extraction and evaluation of its quality
--------------------------------------------------

Total RNA was isolated from total blood cells (\>95% leukocytes) using the Tempus spin RNA isolation kit (Applied Biosystems, Life Technologies Corporation) and following the manufacturer\'s instructions. Total RNA concentration and quality were determined spectrophotometrically at 260 and 280 nm, while RNA integrity was evaluated with formaldehyde agarose gel electrophoresis. Total RNA was stored at −80°C until use.

Reverse transcription and PCR
-----------------------------

One microgram of total RNA from each sample was reverse transcribed into single-stranded cDNA in a 20 μl reaction mixture, using the M-MuLV Reverse Transcriptase (New England Biolabs, Ipswich, MA, USA) and Oligo(dT) primers, following the manufacturer\'s instructions. The success of the synthesis of the single-stranded cDNA was tested by its PCR amplification. PCR was performed using 1.0 μl cDNA, 1.5 mM MgCl~2~, 400 μM dNTPs, 500 nM primers, 1.5 U Dream-Taq DNA polymerase and 1× reaction buffer (Fermentas, Thermo Fisher Scientific Inc.), on a PTC-200 thermocycler (MJ Research Inc., Waltham, MA, USA). Equal amounts (10 μl) of the 108 bp glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and the 177 bp Aqp1 products were electrophoresed on a 2.5% agarose gel, visualized following ethidium bromide staining and photographed under ultraviolet light with a Kodak DC120 digital camera (Rochester, NY, USA).

Quantitative real-time PCR
--------------------------

A highly sensitive quantitative real-time PCR method has been developed for the quantification of both GAPDH and Aqp1 mRNAs, with the use of SYBR® Green Dye detection systems. For the amplification of GAPDH (endogenous reference gene) as well as Aqp1 (target gene) mRNA sequences, gene-specific sets of primers were designed according to the information on the NCBI Sequence database and the advanced software of the Primer Express program. To avoid genomic DNA amplification, the primers, mentioned above, were chosen to span at least two exons. The sequences of the primers used were: for GAPDH, the forward 5′-ATGGGGAAGGTGAAGGTCG-3′ primer, consisting of 19 nucleotides, and the reverse 23-nucleotide 5′-TACATGAGGGCACGGAAGATG-3′ primer, which gave rise to a 108 bp amplicon; for the Aqp1 gene, the forward 5′-GGTGGGGAACAACCAGACG-3′ primer and the reverse 5′-TACATGAGGGCACGGAAGATG-3′ primer, each with a length of 23 nucleotides, produced an amplicon of 177 bp.

Quantitative real-time PCR analysis was performed in 96-well plates on a PTC-200 thermocycler (MJ Research Inc.). The 25 μl reaction mixture contained 5 ng cDNA, 300 nM primers and 1× DyNAmo SYBR® Green PCR Master Mix (Finnzymes, Thermo Fisher Scientific), in which modified Tbr DNA polymerase is included. The thermal protocol conditions consisted of 2 minutes at 50°C and 10 minutes at 95°C polymerase activation step, 40 cycles of denaturation at 95°C for 15 seconds, primer annealing at 54°C for 30 seconds, extension at 72°C for 10 seconds and a final extension step at 72°C for 10 minutes. All samples were amplified in triplicate and the average CT values were calculated for their subsequent expression analysis. Following amplification, a dissociation curve was generated to distinguish the PCR products of interest from the nonspecific ones or any primer dimers, through their particular melting temperatures (Tm), recorded in the software. Using the comparative 2^−ΔΔCT^ method \[[@B12]\] and the baseline samples as a calibrator, the relative quantification of the expression analysis of all blood samples was carried out. GAPDH expression was used for the normalization of Aqp1 expression levels between the different samples.

Polymorphonuclear granulocyte isolation
---------------------------------------

PMNs were isolated from peripheral blood of consecutive healthy volunteers -- blood donors supplied by the Blood Bank of Evangelismos Hospital. Blood was collected in 17% citric acid and allowed to sediment in 3% Dextran/0.9% NaCl for 1 hour. Leukocyte-rich supernatant was separated by centrifugation on Histopaque (Sigma, Sigma-Aldrich Corp.). After lysis of residual erythrocytes by hypotonic shock in ice-cold distilled water, the cells were resuspended in Hank\'s balanced salt solution (Gibco, Life Technologies Corporation, Carlsbad, CA, USA) and stored on ice until use. The cells were counted and diluted to the desired concentration.

Culture of polymorphonuclear granulocytes
-----------------------------------------

PMNs (2×10^6^) were cultured in Hank's balanced salt solution using six-well plates. LPS from *Pseudomonas aeruginosa* 10 (Sigma, Sigma-Aldrich Corp.) was added at a final concentration of 100 ng/ml in the absence or presence of 1 μM NF-κB inhibitor EF-24 (Sigma, Sigma-Aldrich Corp.). The cells were incubated for 3 hours at 37°C. Following incubation, the cells were harvested for RNA and/or protein isolation. Each experiment was independently performed five times.

RNA isolation from polymorphonuclear cells
------------------------------------------

RNA extraction was performed using the Trizol® reagent and the PureLink RNA Mini kit (Invitrogen, Life Technologies Corporation) following the manufacturer's instructions. RNA was stored at −80°C until use. Reverse transcription and quantitative real-time PCR were performed as described above.

Polymorphonuclear cell homogenate
---------------------------------

Approximately 2×10^6^ cells were homogenized in PBS buffer with the addition of 5 μM DTT, 0.1 mM phenylmethylsulfonyl fluoride in isopropanol, and protease inhibitors, using a sonicator (Sonic Dismembrator 550; Fisher Scientific, Loughborough, UK) and 3×10 second bursts. The homogenate was centrifuged in a 5804 R Eppendorf centrifuge (rotor A-4-44; Eppendorf AG, Hamburg, Germany) for 5 minutes at 4°C and 1,000×*g*. The supernatant, referred to as total protein, was collected and stored at −80°C until use.

Protein determination
---------------------

Total protein concentration was determined according to the method of bicinchonic acid \[[@B13]\], using bovine serum albumin as standard.

SDS-polyacrylamide gel electrophoresis
--------------------------------------

SDS-PAGE was performed on a Biorad Mini Protean II electrophoresis apparatus (Bio-Rad, Hercules, CA, USA), as described \[[@B14]\], using 12% polyacrylamide slab gels. Electrophoresis was carried out at 150 V for 1 hour at room temperature.

Immunoblotting of polymorphonuclear homogenates with Aqp1 antibody
------------------------------------------------------------------

Following electrophoresis, samples were transferred onto an Immobilon-P polyvinylidene difluoride membrane (Millipore, 0.45 μl pore size; Millipore Corporation, Billerica, MA, USA). Western transfer was performed on a wet transfer apparatus (Bio-Rad). Immunological detection was performed according to the method of Batteiger and colleagues \[[@B15]\]. The polyclonal antibody against Aqp1 purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz Biotechnology, Inc., Dallas, TX, USA) was used for the detection.

Cell volume measurements
------------------------

Osmotic swelling was monitored as in \[[@B16]\] with slight modifications. Briefly, swelling was monitored at 22°C with a Zeiss Axiovert 25 phase contrast microscope (Carl Zeiss AG, Oberkochen, Germany) with two 10× eyepieces and a 40× objective on a trinocular base, 0.5-numerical aperture long working distance Canon objective equipped with a Canon digital camera (Canon USA Inc., Melville, NY, USA). PMN were transferred from 300 mosM (in) to 150 mosM (out) Hank's balanced salt solution diluted with water. PMN images were taken at 30-second intervals for a total of 600 seconds or until the time of PMN rupture. The relative volume V/Vo, that is the ratio of measured volume at various time-points during the osmotic challenge to the baseline volume, was determined. Changes in volume were measured by ImageJ software (NIH, Bethesda, MD, USA).

Cytokine measurement
--------------------

IL-8 levels were measured at the supernatants of the PMN cells by ELISA, according to the manufacturer's instructions. The human IL-8 immunoassay of R&D Systems Inc. (Minneapolis, MN, USA) was used. This assay uses two different polyclonal antibodies against the cytokines as the catching antibody and the tagging antibody. Samples were assayed in triplicate.

Polymorphonuclear cell nuclear extraction
-----------------------------------------

Nuclear extraction was performed with the kit by Cayman Chemical Company, according to the manufacturer's instructions. In brief, approximately 2×10^6^ cells were homogenized in pre-extraction buffer containing DTT and protease inhibitors. The cytoplasmic extract was removed from the nuclear pellet, which was treated further with extraction buffer containing DTT and protease inhibitors. The extract was incubated on ice for 15 minutes with vortex (5 seconds) every 3 minutes. The suspension was centrifuged in an Espresso centrifuge (Thermo Fisher Scientific Inc.) for 10 minutes at 9,800×*g* at 4°C and transferred into a new microcentrifuge vial. The supernatant, referred to as nuclear extract, was used for the measurement of NF-κB activation. Total protein concentration was determined by the bicinchonic acid method, as mentioned in the Protein determination section above.

NF-κB transcription factor activation measurement
-------------------------------------------------

The activation of NF-κB transcription factor was measured for the nuclear extracts of PMN cells by the Transcription Factor Assay kit (Cayman Chemical Company), according to the manufacturer's instructions. A specific double-stranded DNA sequence containing the NF-κB response element is immobilized onto the bottom of wells of a 96-well plate. NF-κB contained in a nuclear extract binds specifically to the NF-κB response element. NF-κB (p65) is detected by addition of specific primary antibody directed against NF-κB (p65). A secondary antibody conjugated to horseradish peroxidase is added to provide a sensitive colorimetric readout at 450 nm. Samples were assayed in triplicate.

Statistical analysis
--------------------

Data are presented as individual values, mean ± standard deviation for normally distributed variables and median with interquartile range for variables with skewed distribution. For continuous variables, the *t* test was used for two-group comparisons. Associations between qualitative variables were examined by the chi-square test. The Friedman test was used to examine differences within more than two groups, and the Wilcoxon signed-rank test for differences within two groups, one-way and two-way analyses of variance for repeated measures and Kruskal--Wallis analysis of variance followed by Newman--Keuls or Bonferroni's *post-hoc* test were performed as appropriate. The Spearman's rank correlation coefficient was calculated to measure the strength of relationship between levels of Aqp1 expression and time. All aforementioned analyses were performed using the Graphpad prism 5 statistical program (GraphPad Software, Inc., La Jolla, CA, USA). All *P* values are two-sided; *P* \<0.05 was considered significant.

Results
=======

Gene expression profiling in the initial polytrauma patients
------------------------------------------------------------

Isolated RNA from total blood cells (\>95% leukocytes) of the initial five polytrauma patients was hybridized to DNA microarrays (Affymetrix Hu133A 2.0) and genes with statistically significant changes in their expression in all patients were selected as described in detail in Additional file [1](#S1){ref-type="supplementary-material"}. Patients' age was 21.75 ± 2.5 and mean ICU stay was 13 ± 5.2 days. Two of the patients developed sepsis while three developed severe sepsis and acute respiratory distress syndrome \[[@B2],[@B4],[@B17]\]. The two and three patient subgroups were analyzed independently (see Additional file [1](#S1){ref-type="supplementary-material"}) to detect genes that were differentially regulated between them, and which could be involved in pathogenetic mechanisms of the septic process and acute respiratory distress syndrome. We thus found 1,199 genes with statistically significant differences among the replicate values of fold-changes of the two separate patient subgroups (*P* \< 0.05; false discovery rate 5%) (Additional file [1](#S1){ref-type="supplementary-material"}: Table S1).

To validate the selected genes, we compared our results with published expression profiling studies using animal models of LPS-induced and aseptic lung injury, as described in Additional file [1](#S1){ref-type="supplementary-material"}. The comparison analysis yielded three genes that were commonly identified as deregulated both in human patients with severe sepsis and acute respiratory distress syndrome, as well as experimental rodents: the orphan G-protein coupled receptor 182; the dedicator of cytokinesis protein 9, a Cdc42 guanine nucleotide exchange factor; and Aqp1, a 28 KDa water channel protein.

Aqp1 gene expression in septic ICU patients
-------------------------------------------

Since little is known regarding Aqp1 expression in leukocytes, we initially performed PCR on RNA isolated from leukocytes of ICU patients in order to confirm the findings of the gene expression analysis. Aqp1 expression was indeed detected in human leukocytes by end-point PCR (Figure [1](#F1){ref-type="fig"}A), in patients who either developed sepsis or did not. GAPDH was used as a positive control in the PCR reaction (Figure [1](#F1){ref-type="fig"}B).

![**Expression of aquaporin-1 in peripheral leukocytes of septic and nonseptic patients.** Representative expression analysis of aquaporin-1 (Aqp1) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNAs in a nonseptic patient and a septic patient. End-point PCR was performed on RNA isolated from leukocytes of both patients at different time points (B, baseline; D, discharge; S, 6 to 12 hours from sepsis; SS, upon septic shock) and the end products were analyzed on a 2.5% agarose gel. **(A)** Expression of Aqp1 messenger RNA in peripheral leukocytes of one nonseptic patient and one septic patient. Lanes 1 and 2, nonseptic patient; lane 3, molecular weight standards; lanes 4 to 6, septic patient. **(B)** GAPDH was used as a positive control. Lanes 1 and 2, nonseptic patient; lanes 3 to 5, septic patient.](cc12893-1){#F1}

Following confirmation that Aqp1 is expressed in human leukocytes, we prospectively followed temporal trends in Aqp1 mRNA levels using quantitative real-time PCR in ICU patients who were initially nonseptic but later developed nosocomial sepsis and subsequently septic shock (Figure [2](#F2){ref-type="fig"}A); mRNA levels of ICU patients who did not develop sepsis, upon ICU admission and discharge, are shown in Figure [2](#F2){ref-type="fig"}B. All 16 patients who developed sepsis and then septic shock had positive biological fluid cultures, with 11 out of 16 having positive blood cultures. In one-half (8/16) of our patients, sepsis originated from lung infection; no difference in Aqp1 expression was noted in relation to the site of infection (data not shown).

![**Aquaporin-1 expression is induced in leukocytes of patients with sepsis. (A)** Distribution of aquaporin-1 (Aqp1) mRNA levels in septic shock patients at three different time points (baseline, 6 to 12 hours from sepsis and upon septic shock). **(B)** Distribution of Aqp1 mRNA levels in nonseptic patients at two different time points (baseline and discharge). In patients whose ICU stay was not complicated by sepsis, leukocyte Aqp1 levels at discharge did not exceed admission levels. In patients who developed sepsis, however, Aqp1 levels rose steadily from admission to the onset of sepsis and, up to the onset of septic shock. Data are presented as box plots. Line in the box, median value; box edges, 25th to 75th centiles; whiskers, range of values. \**P* \<0.05, \*\**P* \<0.01 from baseline values. \#*P* \<0.05 from sepsis. Differences within groups were tested by the Friedman test (more than two groups) and the Wilcoxon signed-rank test (two groups).](cc12893-2){#F2}

Two of the 16 patients received short-term treatment (1 and 2 days, respectively) with short half-life steroids during their ICU stay. These regimens were far from the time points of Aqp1 expression measurements. Clinical characteristics of the patients are listed in Table [1](#T1){ref-type="table"}. For each patient, Aqp1 levels on admission (baseline) are set as the reference value and the subsequent time points are expressed as the fold-change relative to this. Admission Aqp1 levels in ICU patients did not differ significantly from healthy blood donors (data not shown), nor did the baseline levels of patients who developed sepsis differ from the baseline levels of patients who did not develop sepsis (data not shown). However, upon onset of sepsis, we observed a median 1.7-fold (interquartile range: 0.99 to 2.4) increase in Aqp1 mRNA (*P* = 0.012) (Figure [2](#F2){ref-type="fig"}A). Aqp1 mRNA was also measured upon septic shock and was further elevated, corresponding to a median increase of 3.00-fold (interquartile range: 1.20 to 5.40, *P* = 0.002 from baseline and *P* = 0.023 from sepsis) (Figure [2](#F2){ref-type="fig"}A). Conversely, in patients who did not develop sepsis, Aqp1 expression at discharge did not differ from admission levels (median 0.99-fold, interquartile range: 0.32 to 1.24; Figure [2](#F2){ref-type="fig"}B). In the latter group, two additional patients also received short-term treatments of comparable duration with those of the septic subjects, with short half-life steroids. Spearman's rank correlation coefficient revealed no statistically significant relationship between time (days) in the ICU and levels of Aqp1 expression in both groups.

Aqp1 mRNA and protein expression in human PMNs stimulated by lipopolysaccharide
-------------------------------------------------------------------------------

Since Aqp1 appears upregulated in leukocytes from critically ill patients with nosocomial, mostly Gram-negative sepsis, we probed the role of LPS as an Aqp1 inducer. PMNs, particularly neutrophils, by virtue of their abundance and immediate responsiveness with genomic alterations to bacterial pathogens, became the focus of these studies. After confirming that Aqp1 is expressed in PMNs by end-point PCR (Figure [3](#F3){ref-type="fig"}A), healthy-donor PMNs were stimulated by LPS (100 ng/ml for 3 hours) *in vitro* and Aqp1 mRNA levels were determined by quantitative real-time PCR. In five independent repetitions of this experiment, Aqp1 mRNA expression rose by fourfold on average in the presence of LPS (*P* \<0.01 compared with unstimulated neutrophils) (Figure [3](#F3){ref-type="fig"}B). This was also associated with an increase in Aqp1 protein levels in LPS-stimulated PMNs as detected by immunoblotting (Figure [3](#F3){ref-type="fig"}C).

![**Expression of aquaporin-1 mRNA and protein in polymorphonuclear granulocytes is induced by lipopolysaccharide.** Polymorphonuclear granulocytes (PMNs) isolated from healthy blood donor volunteers were incubated for 3 hours at 37°C in six-well plates with plain cell-culture medium (ctr) or lipopolysaccharide (LPS) from *Pseudomonas aeruginosa* in the absence or presence of NF-κB inhibitor EF-24. **(A)** Representative expression of aquaporin-1 (Aqp1; upper panel) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH; lower panel) mRNAs. End-point PCR was performed on RNA isolated from PMNs, as above and analyzed on 2.5% agarose gel. **(B)** Fold-increase of Aqp1 gene expression, as measured by real-time PCR in PMNs. **(C)** Increase in protein expression of Aqp1 in crude protein samples isolated from PMNs, as analyzed by SDS-PAGE and immunoblotting. Relative Aqp1 protein expression was estimated by densitometry using β-tubulin as a loading control. \*\**P* \<0.01 from corresponding control. \#*P* \<0.05 from corresponding LPS treatment by one-way analysis of variance followed by Newman--Keuls multiple comparison test.](cc12893-3){#F3}

Binding of LPS on Toll-like receptor-4 leads to NF-κB-mediated transcription of target genes, including IL-8; the latter was, in fact, found increased in cell culture supernatants in our experiments (Figure [4](#F4){ref-type="fig"}A), in support of NF-κB activation in our system (Figure [4](#F4){ref-type="fig"}B). Suppression of NF-κB activity by EF-24 (Figure [4](#F4){ref-type="fig"}B), through direct inhibition of IκB kinase, prevented Aqp1 mRNA induction (Figure [3](#F3){ref-type="fig"}B) and protein expression induced by LPS (Figure [3](#F3){ref-type="fig"}C), and IL-8 release (Figure [4](#F4){ref-type="fig"}A).

![**Polymorphonuclear granulocytes are activated by lipopolysaccharide via NF-κB.** Polymorphonuclear granulocytes (PMNs) isolated from healthy blood donors were incubated for 3 hours at 37°C in six-well plates with plain cell-culture medium (ctr) or lipopolysaccharide (LPS) from *Pseudomonas aeruginosa* in the absence or presence of the NF-κB inhibitor EF-24. **(A)** IL-8 levels measured by ELISA on PMN supernatants. **(B)** NF-κB activation as measured by the NF-κB (p65) transcription factor assay on PMN nuclear extracts, expressed as increase of absorbance at 450 nm relative to total protein concentration. The increase in absorbance at 450 nm indicates translocation of NF-κB into the nucleus and DNA binding activity in the nuclear extracts. \**P* \<0.05 from corresponding control. \#*P* \<0.05, \#\#*P* \<0.01 from corresponding LPS treatment by one-way analysis of variance (ANOVA) followed by Newman--Keuls multiple comparison test or two-way ANOVA for repeated measures followed by Bonferoni's *post-hoc* test.](cc12893-4){#F4}

Cell volume measurements
------------------------

We next examined whether the induction of Aqp1 water channel expression by LPS invoked functional changes in PMN plasma membrane permeability. As a surrogate for membrane permeability, we measured PMN relative volume V/Vo in serial micrographs in response to a hypotonic challenge, facilitated by lowering cell culture medium osmolarity from 300 to 150 mOsm/lt. This intervention was associated with a 1.8-fold rise in V/Vo, followed by return to the initial dimensions by 600 seconds (Figure [5](#F5){ref-type="fig"}). With LPS stimulation, however, the PMN V/Vo increase was more pronounced (2.2-fold) and did not return to the baseline value during the 600-second observation time (Figure [5](#F5){ref-type="fig"}, *P* \<0.001) The LPS-triggered permeability response of PMN was inhibited by incubation with HgCl~2~ (0.3 mM for 5 minutes), which is known to block permeability of the Aqp1 water pore by forming a covalent attachment with cysteine 189 in the native molecule \[[@B16]\]. Furthermore, incubation for 15 minutes in 5 mM β-mercaptoethanol (Figure [5](#F5){ref-type="fig"}, three independent experiments, *P* \<0.05), a reducer of protein disulfide bonds, abrogated the action of mercury inhibition on the mercury-sensitive residue of Aqp1 Cys^189^, and restored the effects of LPS.

![**Time-course and Hg**^**2+**^**inhibition of osmotic swelling of polymorphonuclear granulocytes. (A)** Time course and Hg^2+^ inhibition of osmotic swelling of polymorphonuclear granulocytes (PMNs) that were incubated for 3 hours at 37°C either in the absence (control) or presence of lipopolysaccharide (LPS). Cells were then transferred to a hypotonic solution and changes in size were measured by videomicroscopy (see Materials and methods). Where indicated, PMNs were incubated for 5 minutes in buffer containing 0.3 mM HgCI~2~, followed by swelling in the presence of HgCI~2~ (LPS + HgCI~2~). After incubation for 5 minutes in 0.3 mM HgCI~2~, other PMNs were then incubated for 15 minutes in buffer containing 5 mM β-mercaptoethanol and swelling was monitored in the presence of β-mercaptoethanol (LPS + HgCI~2~ + β-merc). Cells were assumed to have a spherical shape with a diameter calculated as the average of the maximum and minimum dimensions of each cell. \**P* \<0.05, \*\*\**P* \<0.001 from control by two-way analysis of variance for repeated measures followed by Bonferoni's *post-hoc* test. **(B)** Microscopy photographs of the time course and osmotic swelling of PMNs (original magnification ×80).](cc12893-5){#F5}

Discussion
==========

Hospital-acquired sepsis is a major cause of mortality in critically ill patients. It is becoming increasingly evident that critical illness is associated with a state of functional immunosuppression \[[@B3],[@B18],[@B19]\], possibly following an acute phase of disproportionate immune system activation. This paradigm has triggered interest in mechanistic understanding of immune system (dys)function in sepsis. In this context, we initially undertook gene expression profiling in a small sample of polytrauma patients, who subsequently acquired sepsis, which returned a large set of genes with differential expression between patients who developed sepsis versus severe sepsis. Owing to the limited size of this pilot study, and the variability inherent to this methodology, we compared our dataset with published work in animal models of acute insults relevant to the ICU population, such as LPS-induced lung injury, a common organ failure in severe sepsis, using the ortholog gene approach. We were thus able to identify Aqp1 as a gene differentially expressed in experimental animals and humans on a consistent basis, indicating a potential involvement in the acute phase response. Importantly, Aqp1 upregulation seems to take place not only in lung tissue \[[@B20]\] but, as shown in our study, also in leukocytes, suggesting a potentially fundamental role in cellular adaptation to acute stress. Although Aqp1 can be found in various tissues and cell types, most notably red blood cells, renal tubules and endothelial cells \[[@B7],[@B21]-[@B24]\], details on Aqp1 expression patterns and functional roles in leukocytes have not yet been described.

Aquaporins regulate cell membrane permeability in most cell types. Most isoforms are selective to water, although some, including aquaporin-7 and aquaporin-9, are permeable to other micromolecules, including urea and glycerol \[[@B25]\]. Leukocytes are known to express aquaporin-9, which is crucial to the formation of filopodia, finger-like membrane protrusions involved in cytokinesis \[[@B26],[@B27]\]. We here report the inducible expression of Aqp1 in leukocytes in clinical sepsis and in response to LPS *in vitro*. This finding reveals a hitherto unknown and potentially fundamental function of this molecule in innate immunity.

To validate the results of the initial pilot gene expression study and meta-analysis, we prospectively followed Aqp1 expression in leukocytes of critically ill patients who were not septic upon ICU admission. We observed an increase in Aqp1 mRNA expression with the appearance of sepsis and septic shock. This effect was not dependent on the length of ICU stay, but was related to the septic process severity and strongly implies that Aqp1 is inducible in humans in the context of the immune response to infection.

Induction in Aqp1 was recently reported by Madonna and coworkers \[[@B28]\] in mouse hearts following septic endotoxemia. In contrast, Aqp1 was found downregulated in human pleural mesothelial cell lines (MET-5A) and primary rat lung microvessel endothelial cells following LPS administration \[[@B29],[@B30]\], as well as in rat and murine models of LPS-induced lung injury \[[@B30],[@B31]\]. In spite of these disparities, which may merely reflect tissue-specific effects of the molecule and differences in experimental design, the data support a novel role for this protein in the stress response to sepsis.

Since ICU-acquired sepsis is most commonly caused by LPS found in Gram-negative bacteria, we tested the role of LPS as an Aqp1 inducer in human PMNs. We found a statistically and biologically significant upregulation of Aqp1 by LPS. This was abrogated by pharmacological disruption of NF-κB signaling pathway, known to transduce signals downstream of the Toll-like-receptor 4, implying that LPS stimulates Aqp1 expression via NF-κB activation. LPS measurably stimulated PMNs, as indicated by a significant increase of IL-8 production and activation of NF-κB.

Placing naive cells in a hypoosmotic environment results in a time-dependent and HgCl~2~-sensitive increase in cell volume. This transient effect is followed by a gradual decline to the baseline values, possibly as a result of a compensatory escape of water and osmotically active molecules from the cell or derecruitment of Aqp1 from the cell membrane. In the presence of LPS, however, membrane permeability remained increased throughout the observation period (600 seconds), consistent with excess Aqp1.

The implications of LPS-induced cell membrane permeability on PMN function in sepsis are unknown. Besides permeability, however, Aqp1 could regulate the PMN stress response by other putative mechanisms. In this context, Aqp1 contributes to endothelial cell migration \[[@B32]\] by forming a critical scaffold for a plasma membrane-associated multiprotein complex important for cytoskeleton remodeling, adhesion and motility. Additionally, the formation of filopodia depends on assembly of an actin cytoskeletal scaffold to support the cell membrane protrusion. An early event in protrusion formation is a local increase in water permeability facilitated by aquaporins, which are thus critical to cell motility \[[@B33]\]. The theoretical significance of the herein demonstrated induction of Aqp1 may be to enhance the neutrophil's ability to migrate to sites of infection. However, additional involvement in neutrophil activation (for example, phagocytosis and oxidative burst) and resistance to apoptosis \[[@B34]\] cannot be excluded.

Our study has the following limitations. The population of our initial study on gene expression profiling (that is, five polytrauma patients) was small due to limitation of funds. However, analysis identified genes, among them Aqp1, with statistically significant changes in their expression. Expression of Aqp1 in patients was probed in total leukocytes isolated from blood, whereas *in vitro* studies were performed on the PMN fraction, which contains mostly neutrophils. Nevertheless, it should be noted that leukocytes from septic patients are mainly neutrophils. Aside from this being one of the first reports of Aqp1 expression in human leukocytes and PMNs, our results document that sepsis and LPS are associated with Aqp1 induction in leukocytes and neutrophils and this could be an important event in neutrophil activation in the setting of sepsis, as well as a biomarker of the latter. Further studies on the regulation of the Aqp1 signal transduction pathway and functional significance may enhance our understanding of the host's immune response, which appears crucial to the outcome of this devastating syndrome.

Conclusions
===========

Based on sepsis-specific overexpression, we propose that increased levels of leukocyte Aqp1 may play a role in sepsis. Aqp1 is upregulated in leukocytes of critically ill patients with hospital-acquired sepsis, while *in vitro* studies support triggering by LPS and transcriptional regulation by NF-κB. Aqp1 induction is moreover associated with increased cell membrane permeability and may therefore be of probable functional significance.

Key messages
============

• Aqp1 is upregulated in leukocytes of critically ill patients with ICU-acquired sepsis.

• In PMNs from healthy donors stimulated with LPS, a statistically and biologically significant upregulation of Aqp1 is observed.

• By disrupting NF-κB signaling in PMNs, we found that Aqp1 was no longer upregulated, indicating that LPS can directly increase Aqp1 expression via NF-κB activation.

• Increased Aqp1 expression leads to increased PMN cell membrane permeability.
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The following additional data are available with the online version of this paper. Additional file [1](#S1){ref-type="supplementary-material"} presents the materials and methods of the gene expression profiling study in detail and the list of deregulated genes in leukocytes of trauma patients resulting from the gene expression profiling study (Additional file [1](#S1){ref-type="supplementary-material"}: Table S1). For the gene expression profiling study, blood samples of five polytauma, initially nonseptic patients were obtained upon admission to the ICU. A second blood sample was obtained from each patient within 48 hours of sepsis. Total RNA was isolated from leukocytes and hybridization was performed using Affymetrix® Human Hu133A 2.0 GeneChip™ arrays. Following validation of results, we selected the genes that were differentially expressed upon development of severe sepsis as compared with sepsis.
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